Atlas Trials

Concert Pharmaceuticals

33 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Concert Pharmaceuticals

RecordFirmDate
Study to Evaluate Multiple Doses of Fluconazole, a CYP3A4 and CYP2C9 Inhibitor, on the Pharmacokinetics of CTP-543 in Healthy Subjects (NCT05478772)Concert Pharmaceuticals2022-07-11
Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy Subjects (NCT05467709)Concert Pharmaceuticals2022-06-21
Study of the Effect of Food on the Bioavailability of the To-Be-Marketed Formulation of CTP-543 in Healthy Volunteers (NCT05467696)Concert Pharmaceuticals2022-06-14
Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of CTP-543 (NCT05468749)Concert Pharmaceuticals2022-06-06
Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of CTP-543 (NCT05467722)Concert Pharmaceuticals2022-06-01
A Randomized Study to Evaluate the Effects of CTP-543 on the QT/QTc Intervals in Health Volunteers (NCT05192369)Concert Pharmaceuticals2022-01-04
Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2) (NCT04797650)Concert Pharmaceuticals2021-06-10
Drug-drug Interaction Study of CTP-543 and Rifampin in Healthy Adult Subjects (NCT04843540)Concert Pharmaceuticals2021-05-19
Drug-drug Interaction Study of CTP-543 and Itraconazole in Healthy Adult Subjects (NCT04743414)Concert Pharmaceuticals2021-03-02
A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata (NCT04784533)Concert Pharmaceuticals2021-02-26
Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1) (NCT04518995)Concert Pharmaceuticals2020-11-23
Drug-drug Interaction Study of CTP-543 and Oral Contraceptives in Healthy Female Subjects (NCT04309643)Concert Pharmaceuticals2020-06-09
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With Schizophrenia (NCT04158687)Concert Pharmaceuticals2019-11-26
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers (NCT04092712)Concert Pharmaceuticals2019-09-05
Multiple Ascending Dose Study of CTP-692 in Healthy Volunteers (NCT03880253)Concert Pharmaceuticals2019-04-10
Food Effect Study of CTP-543 in Healthy Volunteers (NCT03880136)Concert Pharmaceuticals2019-03-25
Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata (NCT03811912)Concert Pharmaceuticals2019-03-21
Study to Assess the Safety and Pharmacokinetic (PK) of CTP-692 in Healthy Volunteers (NCT03830463)Concert Pharmaceuticals2019-01-24
A Study to Compare the Safety, Tolerability, and Pharmacokinetics of CTP-692 Versus D-serine in Healthy Volunteers (NCT03778320)Concert Pharmaceuticals2018-12-14

Track Concert Pharmaceuticals automatically

Every clearance here is in the API, with alerts when new ones post.